GLOOKO
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2011-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.glooko.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Insulin Degludec Titration Using Mobile Insulin Dosing System
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2017-03-27
- Last Posted Date
- 2020-03-05
- Lead Sponsor
- Glooko
- Target Recruit Count
- 240
- Registration Number
- NCT03091712
- Locations
- 🇺🇸
Scripps Whittier Diabetes Institute, San Diego, California, United States
Glooko mHealth Advantage Study
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Glooko
- Target Recruit Count
- 197
- Registration Number
- NCT02974816
- Locations
- 🇺🇸
John Muir Physician Network Clinical Research Center, Concord, California, United States
🇺🇸Sutter Health, Elk Grove, California, United States
🇺🇸Scripps Whittier Diabetes Institute, San Diego, California, United States
News
No news found